Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
Kevin Litchfield(Cancer Research UK), Ron Sinclair, Alexandre Harlé(Institut de Cancérologie de Lorraine), Sergio A. Quezada(Memorial Sloan Kettering Cancer Center), Désirée Schnidrig(The Francis Crick Institute), Katey S.S. Enfield(The Francis Crick Institute), Siow Ming Lee(University College London Hospitals NHS Foundation Trust), Lisa Pickering(Royal Marsden Hospital), Carol Jones(Roche (United States)), Mary Falzon, Iver Nordentoft(Aarhus University Hospital), Robert E. Hynds(The Francis Crick Institute), Lisa L. Gallegos(Roche (United States)), Daniel L. Burgess, Lars Dyrskjøt(Aarhus University Hospital), Dionysis Papadatos-Pastos, Katherine F. Leith(Roche (United States)), Nicholas McGranahan(CRUK Lung Cancer Centre of Excellence), Tariq Enver(London Cancer), Sam M. Janes(University College London), Lewis Au(Royal Marsden NHS Foundation Trust), Samantha M. Hill(University of Arizona), Ariana Huebner(The Francis Crick Institute), Heidi Rosenbaum, Martin Förster, Nicolai J. Birkbak(Brigham and Women's Hospital), Daniel Hochhauser(Royal London Hospital), Aoune Barhoumi(Boston Children's Hospital), Zayd Tippu(Royal Marsden Hospital), Ian Proctor, Hang Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Stacey Stanislaw(Roche (United States)), Stephan Beck, Mariam Jamal-Hanjani(Cancer Research UK), Emilia Lim(The Francis Crick Institute), Lavinia Spain(The Francis Crick Institute), Kai‐Keen Shiu(The Francis Crick Institute), Thomas B.K. Watkins(The Francis Crick Institute), Peter Van Loo, Lisa Thompson(Royal Marsden Hospital), Philippe Lamy(Aarhus University Hospital), Stephen Hazell(Royal Marsden NHS Foundation Trust), Tanya Ahmad(University College London), Henning Walczak, Andrew Rowan(The Francis Crick Institute), John Bridgewater(Roche (United States)), Chris Abbosh(AstraZeneca (United Kingdom)), Stuart Horswell(The Francis Crick Institute), Jennifer Thomas(Royal Marsden Hospital), Peter J. Parker(King's College London)
Cited by 77
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
The extended protein kinase C superfamily
|Biochemical Journal|1998|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k